SPIRIT 2013: new guidance for content of clinical trial protocols

被引：212
作者：
Chan, An-Wen [1 ]
Tetzlaff, Jennifer M. [2 ]
Altman, Douglas G. [3 ]
Dickersin, Kay [4 ]
Moher, David [2 ,5 ]
机构：
[1] Univ Toronto, Womens Coll Hosp, Dept Med, Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada
[2] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada
[3] Univ Oxford, Ctr Stat Med, Oxford, England
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD USA
[5] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada
来源：
LANCET | 2013年 / 381卷 / 9861期
关键词：
D O I：
10.1016/S0140-6736(12)62160-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91 / 92
页数：2
相关论文
共 15 条
  • [1] [Anonymous], BMC MED ETHICS
  • [2] Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases
    Bollyky, Thomas J.
    Cockburn, Iain M.
    Berndt, Ernst
    [J]. CLINICAL TRIALS, 2010, 7 (06) : 719 - 734
  • [3] SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Altman, Douglas G.
    Laupacis, Andreas
    Gotzsche, Peter C.
    Krleza-Jeric, Karmela
    Hrobjartsson, Asbjorn
    Mann, Howard
    Dickersin, Kay
    Berlin, Jesse A.
    Dore, Caroline J.
    Parulekar, Wendy R.
    Summerskill, William S. M.
    Groves, Trish
    Schulz, Kenneth F.
    Sox, Harold C.
    Rockhold, Frank W.
    Rennie, Drummond
    Moher, David
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 158 (03) : 200 - +
  • [4] SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
    Chan, An-Wen
    Tetzlaff, Jennifer M.
    Gotzsche, Peter C.
    Altman, Douglas G.
    Mann, Howard
    Berlin, Jesse A.
    Dickersin, Kay
    Hrobjartsson, Asbjorn
    Schulz, Kenneth F.
    Parulekar, Wendy R.
    Krleza-Jeric, Karmela
    Laupacis, Andreas
    Moher, David
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [5] Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles
    Chan, AW
    Hróbjartsson, A
    Haahr, MT
    Gotzsche, PC
    Altman, DG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20): : 2457 - 2465
  • [6] Comparison of protocols and registry entries to published reports for randomised controlled trials
    Dwan, Kerry
    Altman, Douglas G.
    Cresswell, Lynne
    Blundell, Michaela
    Gamble, Carrol L.
    Williamson, Paula R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [7] Measuring the Incidence, Causes, and Repercussions of Protocol Amendments
    Getz, Kenneth A.
    Zuckerman, Rachael
    Cropp, Anne B.
    Hindle, Anna L.
    Krauss, Randy
    Kaitin, Kenneth I.
    [J]. DRUG INFORMATION JOURNAL, 2011, 45 (03): : 265 - 275
  • [8] Access to data in industry-sponsored trials
    Lundh, Andreas
    Krogsboll, Lasse T.
    Gotzsche, Peter C.
    [J]. LANCET, 2011, 378 (9808) : 1995 - 1996
  • [9] National Research Council Panel on Handling Missing Data in Clinical Trials, 2010, The Prevention and Treatment of Missing Data in Clinical Trials
  • [10] Russ Hagen, 2009, Ger Med Sci, V7, pDoc07, DOI 10.3205/000066
12